Review of peptides in breast cancer therapy covers tumor-targeting peptides, peptide-drug conjugates, antimicrobial peptides, and emerging peptide-based drug delivery systems.
Key findingReview of peptides in breast cancer therapy covers tumor-targeting peptides, peptide-drug conjugates
What the researchers found
Review of peptides in breast cancer therapy covers tumor-targeting peptides, peptide-drug conjugates, antimicrobial peptides, and emerging peptide-based drug delivery systems.
Why it matters
This finding has implications for the millions of patients using or considering peptide-based therapies.
The numbers in context
Review article covering multiple peptide applications — specific data from individual studies referenced within.
How the study worked
Clinical or preclinical study with methodology detailed in the full publication.
Who was studied
Review covering breast cancer research across preclinical and clinical studies
What this study cannot tell us
Study-specific limitations are discussed in the full publication. As with all research, findings should be interpreted in the context of study design and population.
How to read the evidence
Evidence grade assessment based on study design and methodology detailed in the full publication.
When this study was published
Published in 2025. Reflects current state of peptide therapeutic research.
The bigger picture
This study adds to the rapidly expanding evidence base for peptide-based therapeutics across multiple medical specialties.
Questions still open
- What are the long-term implications of these findings?
- How do these results compare to other studies in this area?
- What further research is needed to confirm and extend these findings?
Common questions
What does this study mean for patients?
How reliable are these findings?
Read the original research
Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies.
Pathology, research and practice, 269, 155946
Citation
Alaei, Elmira; Hashemi, Farid; Farahani, Najma; Tahmasebi, Safa; Nabavi, Noushin; Daneshi, Salman; Mahmoodieh, Behnaz; Rahimzadeh, Payman; Taheriazam, Afshin; Hashemi, Mehrdad. (2025). Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies.. Pathology, research and practice, 269, 155946. https://doi.org/10.1016/j.prp.2025.155946